Subgroup efficacy analysis: Orthostatic hypotension questionnaire composite score in patients with neurogenic orthostatic hypotension treated with droxidopa

被引：0
|
作者：
Wenning, G.
Low, P.
Szakacs, C.
Kaufmann, H.
机构：
来源：
MOVEMENT DISORDERS | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1305
引用
收藏
页码：S429 / S429
页数：1
相关论文
共 50 条
  • [31] Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Clément François
    Gerald J. Rowse
    L. Arthur Hewitt
    Pamela Vo
    Robert A. Hauser
    BMC Neurology, 16
  • [32] Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases
    Perez-Lloret, Santiago
    Quarracino, Cecilia
    Otero-Losada, Matilde
    Rascol, Olivier
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (06) : 635 - 645
  • [33] Neurogenic orthostatic hypotension - management update and role of droxidopa
    Vijayan, Joy
    Sharma, Vijay K.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 915 - 923
  • [34] Cognitive and Behavioral Changes in Patients Treated With Droxidopa for Neurogenic Orthostatic Hypotension: A Retrospective Review
    McDonell, Katherine E.
    Shibao, Cyndya A.
    Biaggioni, Italo
    Hartman, Adam
    Robertson, David
    Claassen, Daniel O.
    COGNITIVE AND BEHAVIORAL NEUROLOGY, 2019, 32 (03) : 179 - 184
  • [35] Characteristics of patients initiating droxidopa for the treatment of neurogenic orthostatic hypotension (nOH)
    Francois, C.
    McLeod, K.
    Duhig, A.
    Ogbonnaya, A.
    Quillen, A.
    Cannon, J.
    Padilla, B.
    Shibao, C. A.
    Biaggioni, I.
    MOVEMENT DISORDERS, 2016, 31 : S147 - S147
  • [36] Efficacy of midodrine for neurogenic orthostatic hypotension
    Berlin, I
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (05): : 388 - 388
  • [37] Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease
    Goodman, Brent P.
    Claassen, Daniel
    Mehdirad, Ali
    CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S17 - S19
  • [38] Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease
    Brent P. Goodman
    Daniel Claassen
    Ali Mehdirad
    Clinical Autonomic Research, 2017, 27 : 17 - 19
  • [39] Droxidopa: A Review of Its Use in Symptomatic Neurogenic Orthostatic Hypotension
    Keating, Gillian M.
    DRUGS, 2015, 75 (02) : 197 - 206
  • [40] Number-needed-to-treat analysis of droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Francois, C.
    Rowse, G. J.
    Hauser, R. A.
    Hewitt, L. A.
    MOVEMENT DISORDERS, 2015, 30 : S86 - S86
12345